2.99
-0.212(-6.62%)
Currency In USD
| Previous Close | 3.2 |
| Open | 3.22 |
| Day High | 3.3 |
| Day Low | 2.94 |
| 52-Week High | 6.9 |
| 52-Week Low | 1.69 |
| Volume | 125,185 |
| Average Volume | 81,607 |
| Market Cap | 7.72M |
| PE | -0.96 |
| EPS | -3.13 |
| Moving Average 50 Days | 3.5 |
| Moving Average 200 Days | 3.05 |
| Change | -0.21 |
If you invested $1000 in Creative Medical Technology Holdings, Inc. (CELZ) 10 years ago, it would be worth $0.36 as of November 13, 2025 at a share price of $2.99. Whereas If you bought $1000 worth of Creative Medical Technology Holdings, Inc. (CELZ) shares 5 years ago, it would be worth $398.67 as of November 13, 2025 at a share price of $2.99.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Creative Medical Technology Holdings, Inc. Ignites Next-Gen Regenerative BioDefense Initiative for U.S. Veterans Exposed to Burn Pits
GlobeNewswire Inc.
Oct 30, 2025 1:15 PM GMT
Selects Greenstone Biosciences to Accelerate AI-Driven iPSC Precision Medicine PlatformPHOENIX, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”), a clinical-stage lead
Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.2 Million Gross Proceeds
GlobeNewswire Inc.
Oct 29, 2025 1:00 PM GMT
PHOENIX, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc., (Nasdaq: CELZ) (the “Company”), a clinical-stage biotechnology company pioneering regenerative immunotherapy, today announced that it has entered into agreements
Creative Medical Technology Holdings Issues Letter to Shareholders
GlobeNewswire Inc.
Oct 27, 2025 12:15 PM GMT
Ongoing Phase II Clinical Trials, Recently Issued Patents, and AI Integration Initiatives Set the Stage for Continuing Progress in 2026PHOENIX, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative M